Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

331.38 +6.99 (+2.15%)

Streaming Delayed Price Updated: 3:16 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

66 67 Next >

P/E Ratio Insights for Amgen ↗

December 06, 2023

Via Benzinga

Looking Into Amgen's Recent Short Interest ↗

November 30, 2023

Via Benzinga

Analyst Ratings for Amgen ↗

November 29, 2023

Via Benzinga

1 Spectacular Dividend Stock Every Investor Should Consider ↗

November 28, 2023

This biotech pioneer has been an exceptional growth and income stock.

Via The Motley Fool

Why NASDAQ:AMGN is a Top Pick for Dividend Investors. ↗

November 27, 2023

Why AMGEN INC (NASDAQ:AMGN) qualifies as a good dividend investing stock.

Via Chartmill

Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors ↗

November 24, 2023

Via Benzinga

P/E Ratio Insights for Amgen ↗

November 22, 2023

Via Benzinga

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗

November 17, 2023

Biotech companies are edging closer to finding the answers behind Alzheimer's disease.

Via Investor's Business Daily

Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors ↗

November 10, 2023

Via Benzinga

2 Top Biotech Stocks to Buy Right Now ↗

November 10, 2023

Don't give up on these stocks too fast.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 15, 2023

Via Benzinga

20 Analysts Have This to Say About Amgen ↗

November 09, 2023

Via Benzinga

Amgen's Rare Autoimmune Disease Candidate Shows Improvement In Disease Burden In Treating Sjögren's Syndrome ↗

November 08, 2023

Amgen Inc (NASDAQ: AMGN) released new

Via Benzinga

Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review ↗

November 03, 2023

Bulls are back in control as the major indexes confirmed the uptrend this week.

Via Investor's Business Daily

Earnings Outlook For Amgen ↗

October 30, 2023

Via Benzinga

Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗

October 30, 2023

S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.

Via Benzinga

Topics Economy Stocks

Amgen Wins Big With FDA, Analyst Sees Soaring Potential ↗

November 02, 2023

The FDA approval of Amgen, Inc’s (NASDAQ: AMGN) biosimilar version of Johnson & Johnson's (NYSE: JNJ) psoriasis treatment, Stelara, for multiple inflammatory diseases sent

Via Benzinga

These Analysts Revise Their Forecasts On Amgen After Q3 Results ↗

November 01, 2023

Amgen Inc (NASDAQ: AMGN) reported mixed third-quarter financial results.

Via Benzinga

5 Dow stocks to track during the market correction

November 01, 2023

The Dow Jones Industrial Average is struggling in correction territory, but savvy investors keep an eye on resilient stocks like Microsoft, Amgen, and Walmart.

Via MarketBeat

Topics ETFs Stocks

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

Via Investor Brand Network

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

Via FinancialNewsMedia

Investor patience tested as pharmaceutical stocks take a tumble

November 01, 2023

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Via MarketBeat

Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision ↗

November 01, 2023

The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely...

Via Benzinga

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 31, 2023

Via Benzinga

Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200 ↗

October 31, 2023

To gain an edge, this is what you need to know today.

Via Benzinga

Topics Economy

Amgen Lifts Annual Outlook After Q3 Performance, But Stock Still Falls - Here's Why ↗

October 31, 2023

Amgen Inc (NASDAQ: AMGN) reported Q3 FY23 sales of $6.90 billion, slightly missin

Via Benzinga

Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel Sales ↗

October 31, 2023

The company just finished its acquisition of Horizon Therapeutics this month.

Via Investor's Business Daily

U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive ↗

October 31, 2023

US stocks are priming for a modestly higher open on Tuesday as traders look to another slew of earnings and the Fed decision.

Via Benzinga

Topics Economy

Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient ↗

October 30, 2023

This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.

Via The Motley Fool

2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now ↗

October 29, 2023

These two defensive dividend stocks sport compelling valuations and attractive yields.

Via The Motley Fool

Topics Stocks

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Amgen (NQ:AMGN)

All News about Amgen

Starting at $3.75/week.

Subscribe Today